Disease Information
General Information of the Disease (ID: DIS00142)
Name |
Surgical wound infection
|
---|---|
ICD |
ICD-11: NE81
|
Resistance Map |
Type(s) of Resistant Mechanism of This Disease
ADTT: Aberration of the Drug's Therapeutic Target
IDUE: Irregularity in Drug Uptake and Drug Efflux
Drug Resistance Data Categorized by Drug
Approved Drug(s)
11 drug(s) in total
Chloramphenicol
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Key Molecule: Lincomycin resistance efflux pump (LMRS) | [1] | |||
Resistant Disease | Staphylococcus aureus infection [ICD-11: 1B54.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Chloramphenicol | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli kAM32 | 562 | ||
Staphylococcus aureus OM505 | 1280 | |||
Experiment for Molecule Alteration |
Whole genome sequence assay; Allelic frequency measurement assay | |||
Experiment for Drug Resistance |
Broth microdilution method assay | |||
Mechanism Description | LmrS is a multidrug efflux pump of the major facilitator superfamily from staphylococcus aureus. |
Clarithromycin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||
Key Molecule: Erythromycin resistance protein (ERM38) | [2] | |||
Resistant Disease | Mycobacterium smegmatis infection [ICD-11: 1B2Z.3] | |||
Molecule Alteration | Expression | Inherence |
||
Resistant Drug | Clarithromycin | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Mycobacterium smegmatis mc2155 | 246196 | ||
Mycobacterium smegmatis mc2155/pMIP12 | 246196 | |||
Mycobacterium smegmatis mc2155/pOMV20 | 246196 | |||
Mycobacterium smegmatis mc2155/pOMV30 | 246196 | |||
Experiment for Molecule Alteration |
MALDI mass spectrometry assay | |||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | Erm (38) is a specific dimethyltransferase. The strain obtained drug resistance by adding two methyl groups to A2058 in Mycobacterium 23SrRNA. | |||
Key Molecule: Erythromycin resistance protein (ERM38) | [2] | |||
Resistant Disease | Mycobacterium smegmatis infection [ICD-11: 1B2Z.3] | |||
Molecule Alteration | Expression | Inherence |
||
Resistant Drug | Clarithromycin | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Mycobacterium smegmatis mc2155 | 246196 | ||
Mycobacterium smegmatis mc2155/pMIP12 | 246196 | |||
Mycobacterium smegmatis mc2155/pOMV20 | 246196 | |||
Mycobacterium smegmatis mc2155/pOMV30 | 246196 | |||
Experiment for Molecule Alteration |
MALDI mass spectrometry assay | |||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | Erm (38) is a specific dimethyltransferase. The strain obtained drug resistance by adding two methyl groups to A2058 in Mycobacterium 23SrRNA. |
Clindamycin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||
Key Molecule: Erythromycin resistance protein (ERM38) | [2] | |||
Resistant Disease | Mycobacterium smegmatis infection [ICD-11: 1B2Z.3] | |||
Molecule Alteration | Expression | Inherence |
||
Resistant Drug | Clindamycin | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Mycobacterium smegmatis mc2155 | 246196 | ||
Mycobacterium smegmatis mc2155/pMIP12 | 246196 | |||
Mycobacterium smegmatis mc2155/pOMV20 | 246196 | |||
Mycobacterium smegmatis mc2155/pOMV30 | 246196 | |||
Experiment for Molecule Alteration |
MALDI mass spectrometry assay | |||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | Erm (38) is a specific dimethyltransferase. The strain obtained drug resistance by adding two methyl groups to A2058 in Mycobacterium 23SrRNA. | |||
Key Molecule: Erythromycin resistance protein (ERM38) | [2] | |||
Resistant Disease | Mycobacterium smegmatis infection [ICD-11: 1B2Z.3] | |||
Molecule Alteration | Expression | Inherence |
||
Resistant Drug | Clindamycin | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Mycobacterium smegmatis mc2155 | 246196 | ||
Mycobacterium smegmatis mc2155/pMIP12 | 246196 | |||
Mycobacterium smegmatis mc2155/pOMV20 | 246196 | |||
Mycobacterium smegmatis mc2155/pOMV30 | 246196 | |||
Experiment for Molecule Alteration |
MALDI mass spectrometry assay | |||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | Erm (38) is a specific dimethyltransferase. The strain obtained drug resistance by adding two methyl groups to A2058 in Mycobacterium 23SrRNA. |
Erythromycin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||
Key Molecule: Erythromycin resistance protein (ERM38) | [2] | |||
Resistant Disease | Mycobacterium smegmatis infection [ICD-11: 1B2Z.3] | |||
Molecule Alteration | Expression | Inherence |
||
Resistant Drug | Erythromycin | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Mycobacterium smegmatis mc2155 | 246196 | ||
Mycobacterium smegmatis mc2155/pMIP12 | 246196 | |||
Mycobacterium smegmatis mc2155/pOMV20 | 246196 | |||
Mycobacterium smegmatis mc2155/pOMV30 | 246196 | |||
Experiment for Molecule Alteration |
MALDI mass spectrometry assay | |||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | Erm (38) is a specific dimethyltransferase. The strain obtained drug resistance by adding two methyl groups to A2058 in Mycobacterium 23SrRNA. | |||
Key Molecule: Erythromycin resistance protein (ERM38) | [2] | |||
Resistant Disease | Mycobacterium smegmatis infection [ICD-11: 1B2Z.3] | |||
Molecule Alteration | Expression | Inherence |
||
Resistant Drug | Erythromycin | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Mycobacterium smegmatis mc2155 | 246196 | ||
Mycobacterium smegmatis mc2155/pMIP12 | 246196 | |||
Mycobacterium smegmatis mc2155/pOMV20 | 246196 | |||
Mycobacterium smegmatis mc2155/pOMV30 | 246196 | |||
Experiment for Molecule Alteration |
MALDI mass spectrometry assay | |||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | Erm (38) is a specific dimethyltransferase. The strain obtained drug resistance by adding two methyl groups to A2058 in Mycobacterium 23SrRNA. | |||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Key Molecule: Lincomycin resistance efflux pump (LMRS) | [1] | |||
Resistant Disease | Staphylococcus aureus infection [ICD-11: 1B54.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Erythromycin | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli kAM32 | 562 | ||
Staphylococcus aureus OM505 | 1280 | |||
Experiment for Molecule Alteration |
Whole genome sequence assay; Allelic frequency measurement assay | |||
Experiment for Drug Resistance |
Broth microdilution method assay | |||
Mechanism Description | LmrS is a multidrug efflux pump of the major facilitator superfamily from staphylococcus aureus. |
Florfenicol
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Key Molecule: Lincomycin resistance efflux pump (LMRS) | [1] | |||
Resistant Disease | Staphylococcus aureus infection [ICD-11: 1B54.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Florfenicol | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli kAM32 | 562 | ||
Staphylococcus aureus OM505 | 1280 | |||
Experiment for Molecule Alteration |
Whole genome sequence assay; Allelic frequency measurement assay | |||
Experiment for Drug Resistance |
Broth microdilution method assay | |||
Mechanism Description | LmrS is a multidrug efflux pump of the major facilitator superfamily from staphylococcus aureus. |
Kanamycin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Key Molecule: Lincomycin resistance efflux pump (LMRS) | [1] | |||
Resistant Disease | Staphylococcus aureus infection [ICD-11: 1B54.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Kanamycin | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli kAM32 | 562 | ||
Staphylococcus aureus OM505 | 1280 | |||
Experiment for Molecule Alteration |
Whole genome sequence assay; Allelic frequency measurement assay | |||
Experiment for Drug Resistance |
Broth microdilution method assay | |||
Mechanism Description | LmrS is a multidrug efflux pump of the major facilitator superfamily from staphylococcus aureus. |
Linezolid
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Key Molecule: Lincomycin resistance efflux pump (LMRS) | [1] | |||
Resistant Disease | Staphylococcus aureus infection [ICD-11: 1B54.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Linezolid | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli kAM32 | 562 | ||
Staphylococcus aureus OM505 | 1280 | |||
Experiment for Molecule Alteration |
Whole genome sequence assay; Allelic frequency measurement assay | |||
Experiment for Drug Resistance |
Broth microdilution method assay | |||
Mechanism Description | LmrS is a multidrug efflux pump of the major facilitator superfamily from staphylococcus aureus. |
Quinupristin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||
Key Molecule: Erythromycin resistance protein (ERM38) | [2] | |||
Resistant Disease | Mycobacterium smegmatis infection [ICD-11: 1B2Z.3] | |||
Molecule Alteration | Expression | Inherence |
||
Resistant Drug | Quinupristin | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Mycobacterium smegmatis mc2155 | 246196 | ||
Mycobacterium smegmatis mc2155/pMIP12 | 246196 | |||
Mycobacterium smegmatis mc2155/pOMV20 | 246196 | |||
Mycobacterium smegmatis mc2155/pOMV30 | 246196 | |||
Experiment for Molecule Alteration |
MALDI mass spectrometry assay | |||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | Erm (38) is a specific dimethyltransferase. The strain obtained drug resistance by adding two methyl groups to A2058 in Mycobacterium 23SrRNA. | |||
Key Molecule: Erythromycin resistance protein (ERM38) | [2] | |||
Resistant Disease | Mycobacterium smegmatis infection [ICD-11: 1B2Z.3] | |||
Molecule Alteration | Expression | Inherence |
||
Resistant Drug | Quinupristin | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Mycobacterium smegmatis mc2155 | 246196 | ||
Mycobacterium smegmatis mc2155/pMIP12 | 246196 | |||
Mycobacterium smegmatis mc2155/pOMV20 | 246196 | |||
Mycobacterium smegmatis mc2155/pOMV30 | 246196 | |||
Experiment for Molecule Alteration |
MALDI mass spectrometry assay | |||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | Erm (38) is a specific dimethyltransferase. The strain obtained drug resistance by adding two methyl groups to A2058 in Mycobacterium 23SrRNA. |
Streptomycin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Key Molecule: Lincomycin resistance efflux pump (LMRS) | [1] | |||
Resistant Disease | Staphylococcus aureus infection [ICD-11: 1B54.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Streptomycin | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli kAM32 | 562 | ||
Staphylococcus aureus OM505 | 1280 | |||
Experiment for Molecule Alteration |
Whole genome sequence assay; Allelic frequency measurement assay | |||
Experiment for Drug Resistance |
Broth microdilution method assay | |||
Mechanism Description | LmrS is a multidrug efflux pump of the major facilitator superfamily from staphylococcus aureus. |
Telithromycin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||
Key Molecule: Erythromycin resistance protein (ERM38) | [2] | |||
Resistant Disease | Mycobacterium smegmatis infection [ICD-11: 1B2Z.3] | |||
Molecule Alteration | Expression | Inherence |
||
Resistant Drug | Telithromycin | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Mycobacterium smegmatis mc2155 | 246196 | ||
Mycobacterium smegmatis mc2155/pMIP12 | 246196 | |||
Mycobacterium smegmatis mc2155/pOMV20 | 246196 | |||
Mycobacterium smegmatis mc2155/pOMV30 | 246196 | |||
Experiment for Molecule Alteration |
MALDI mass spectrometry assay | |||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | Erm (38) is a specific dimethyltransferase. The strain obtained drug resistance by adding two methyl groups to A2058 in Mycobacterium 23SrRNA. | |||
Key Molecule: Erythromycin resistance protein (ERM38) | [2] | |||
Resistant Disease | Mycobacterium smegmatis infection [ICD-11: 1B2Z.3] | |||
Molecule Alteration | Expression | Inherence |
||
Resistant Drug | Telithromycin | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Mycobacterium smegmatis mc2155 | 246196 | ||
Mycobacterium smegmatis mc2155/pMIP12 | 246196 | |||
Mycobacterium smegmatis mc2155/pOMV20 | 246196 | |||
Mycobacterium smegmatis mc2155/pOMV30 | 246196 | |||
Experiment for Molecule Alteration |
MALDI mass spectrometry assay | |||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | Erm (38) is a specific dimethyltransferase. The strain obtained drug resistance by adding two methyl groups to A2058 in Mycobacterium 23SrRNA. |
Trimethoprim
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Key Molecule: Lincomycin resistance efflux pump (LMRS) | [1] | |||
Resistant Disease | Staphylococcus aureus infection [ICD-11: 1B54.0] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Drug | Trimethoprim | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli kAM32 | 562 | ||
Staphylococcus aureus OM505 | 1280 | |||
Experiment for Molecule Alteration |
Whole genome sequence assay; Allelic frequency measurement assay | |||
Experiment for Drug Resistance |
Broth microdilution method assay | |||
Mechanism Description | LmrS is a multidrug efflux pump of the major facilitator superfamily from staphylococcus aureus. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.